These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1622426)

  • 1. Pharmacologic desensitization by intravenous protocols.
    Steinberg DG; Borish LC; Rosenwasser LJ
    Arthritis Rheum; 1992 Jul; 35(7):842-3. PubMed ID: 1622426
    [No Abstract]   [Full Text] [Related]  

  • 2. Allopurinol sensitivity in a patient with chronic tophaceous gout: success of intravenous desensitization after failure of oral desensitization.
    Walz-LeBlanc BA; Reynolds WJ; MacFadden DK
    Arthritis Rheum; 1991 Oct; 34(10):1329-31. PubMed ID: 1930322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral desensitization in patients with chronic tophaceous gout and allopurinol hypersensitivity.
    Gillott TJ; Whallett A; Zaphiropoulos G
    Rheumatology (Oxford); 1999 Jan; 38(1):85-6. PubMed ID: 10334688
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous desensitization to allopurinol in a heart transplant patient with gout.
    Schumacher MJ; Copeland JG
    Ann Allergy Asthma Immunol; 2004 Mar; 92(3):374-6. PubMed ID: 15049403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid oral allopurinol desensitization in a patient with chronic myeloid leukemia.
    Toker O; Tvito A; Rowe JM; Ashkenazi J; Ganzel C; Tal Y; Shalit M
    Isr Med Assoc J; 2014 Jul; 16(7):461-2. PubMed ID: 25167698
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful desensitisation of allopurinol-induced erythema multiforme.
    Fonseka MM; Sathischandra H; Jayamanne SF; de Silva HJ
    Ceylon Med J; 1999 Dec; 44(4):190-1. PubMed ID: 10895280
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rush desensitization to drugs: elements for protocol rationalization].
    Moneret-Vautrin DA; Kanny G; Beaudouin E
    Allerg Immunol (Paris); 1999 Mar; 31(3):73-8. PubMed ID: 10226680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization to allopurinol in patients with gout and cutaneous reactions.
    Fam AG; Lewtas J; Stein J; Paton TW
    Am J Med; 1992 Sep; 93(3):299-302. PubMed ID: 1388001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytokine production after in vivo desensitization in an allopurinol-induced delayed allergic reaction.
    Martínez-Aranguren R; Gamboa PM; García-Lirio E; Alonso A; Sanz ML
    Ann Allergy Asthma Immunol; 2012 Apr; 108(4):280-1. PubMed ID: 22469450
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral desensitization to rifampin and ethambutol in mycobacterial disease.
    Matz J; Borish LC; Routes JM; Rosenwasser LJ
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):815-7. PubMed ID: 8118654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization to allopurinol in a patient with previous failed desensitization.
    Tanna SB; Barnes JF; Seth SK
    Ann Pharmacother; 1999 Nov; 33(11):1180-3. PubMed ID: 10573316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful desensitization to fixed drug eruption: the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization.
    Teraki Y; Shiohara T
    Dermatology; 2004; 209(1):29-32. PubMed ID: 15237264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple intravenous antimicrobial desensitization method for pediatric patients.
    De Maria C; Lebel D; Desroches A; Gauvin F
    Am J Health Syst Pharm; 2002 Aug; 59(16):1532-6. PubMed ID: 12185828
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral desensitization in childhood (author's transl)].
    Stemmann EA; Wegner F; Schachoff R; Reinhardt D
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():302-4. PubMed ID: 111236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified protocol for rapid desensitization to chemotherapy agents.
    Vidal C; Méndez-Brea P; López-Freire S; Bernárdez B; Lamas MJ; Armisén M; Rodríguez V; Luna I; Castro-Murga M
    J Allergy Clin Immunol Pract; 2016; 4(5):1003-5. PubMed ID: 27349174
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical efficacy and lack of toxicity of allopurinol (NSC-1390) given intravenously.
    Brown CH; Stashick E; Carbone PP
    Cancer Chemother Rep; 1970 Apr; 54(2):125-9. PubMed ID: 4946002
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of allopurinol on the first-pass metabolism of 6-mercaptopurine in the rat.
    Sasaki H; Tsuru K; Nakamura J; Konishi R; Shibasaki J
    Biochem Pharmacol; 1987 Dec; 36(23):4175-6. PubMed ID: 3689444
    [No Abstract]   [Full Text] [Related]  

  • 19. [Practical aspects of oral hyposensitization of pollinosis patients by pollen capsules. Requests for protocols from general practice].
    Stickl H
    Fortschr Med; 1981 Dec; 99(47-48):1991-3. PubMed ID: 7327493
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled penicillin anaphylaxis leading to desensitization.
    Graybill JR; Sande MA; Reinarz JA; Shapiro SR
    South Med J; 1974 Jan; 67(1):62-4. PubMed ID: 4808991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.